Cargando…
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
High-frequency mutations in tumor genomes could be exploited as an asset for developing tumor vaccines. In recent years, with the tremendous breakthrough in genomics, intelligence algorithm, and in-depth insight of tumor immunology, it has become possible to rapidly target genomic alterations in tum...
Autores principales: | Yuan, Yuan, Gao, Fan, Chang, Ying, Zhao, Qiu, He, Xingxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845107/ https://www.ncbi.nlm.nih.gov/pubmed/36650562 http://dx.doi.org/10.1186/s40364-023-00449-w |
Ejemplares similares
-
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
por: Wang, Bolin, et al.
Publicado: (2023) -
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
por: Wadhwa, Abishek, et al.
Publicado: (2020) -
mRNA cancer vaccines: Advances, trends and challenges
por: He, Qing, et al.
Publicado: (2022) -
Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023) -
The role of YWHAZ in cancer: A maze of opportunities and challenges
por: Gan, Yun, et al.
Publicado: (2020)